Low-Intensity Focused Ultrasound for Epilepsy

This trial explores how Low-Intensity Focused Ultrasound (LIFU) can assist people with epilepsy, particularly those with hard-to-treat seizures originating in the temporal lobe. The primary aim is to determine if LIFU applied to the brain can effectively manage these seizures. Participants will receive either the actual LIFU treatment or a sham (inactive) version to compare outcomes. The trial is suitable for individuals with an RNS system (a device implanted in the brain to help control seizures), a history of epilepsy, internet access, and recent brain scans. As an unphased trial, it provides a unique opportunity to investigate innovative treatment options for epilepsy.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that Low-Intensity Focused Ultrasound (LIFU) is generally safe for people. Some studies found that patients with medication-resistant epilepsy experienced fewer seizures after LIFU treatment. These studies primarily assessed the treatment's safety and tolerability. Although research remains in its early stages, no serious side effects have been reported. This suggests that LIFU might be a safe option for those considering participation in a clinical trial. However, discussing any potential risks with a doctor before participating is always important.¹²³⁴⁵

Most treatments for epilepsy focus on medication or surgery to control seizures. However, Low-Intensity Focused Ultrasound (LIFU) offers a novel approach by using sound waves to target specific brain regions, like the entorhinal cortex, without the need for invasive procedures. This technique stands out because it has the potential to modulate brain activity more precisely and with fewer side effects than traditional methods. Researchers are excited because LIFU could offer a non-invasive alternative that might work where other treatments have failed, providing new hope for patients with drug-resistant epilepsy.

Research has shown that Low-Intensity Focused Ultrasound (LIFU) may help reduce seizures. Animal studies found that LIFU can decrease seizures without harming the brain, resulting in fewer and shorter seizures. This trial will compare the effects of real LIFU treatment with a sham LIFU treatment. Although most research comes from animal studies, these early findings offer hope for its potential use in people with epilepsy.¹²⁶⁷⁸